Syndax Pharmaceuticals Aktie
WKN DE: A2AFL6 / ISIN: US87164F1057
03.03.2025 13:07:57
|
Syndax Pharma Q4 Loss Increases, Misses Estimates
(RTTNews) - Syndax Pharma (SNDX) announced Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.
The company's earnings came in at -$94.17 million, or -$1.10 per share. This compares with -$72.47 million, or -$1.00 per share, last year.
Analysts on average had expected the company to earn -$0.23 per share. Analysts' estimates typically exclude special items.
Syndax Pharma earnings at a glance (GAAP) :
-Earnings: -$94.17 Mln. vs. -$72.47 Mln. last year. -EPS: -$1.10 vs. -$1.00 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Syndax Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Syndax Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Syndax Pharmaceuticals Inc | 11,10 | -1,77% |
|